Gowling WLG's Life Sciences team has received the award for ”Impact Deal of the Year” at the LMG Life Sciences 2024 Americas Awards.
The award recognizes the team’s work in the CNL and AECL joint venture with ITM deal, where ITM and CNL announced the launch of their joint venture in the global production of rare medical isotope.
Gowling WLG advised ITM with respect to this joint venture with a team led by Marcus Hinkley, supported by Ahab Abdel-Aziz and Magda Hanebach (nuclear); Anita Nador (IP/life sciences); Joseph McDonald (corporate); Ian Macdonald and Elad Gafni (competition); Michael Bussmann (tax); and Matthijs van Gaalen (lending). They were assisted by law clerks Charmaine Craig and Rhena Verayo, and legal assistant Karen Gorman.
The LMG Life Sciences awards program honours the top life sciences practitioners and firms in the US, Canada, Brazil and Europe. Since 2014, winners are selected through rigorous research, recognizing innovative work in the sector over a 12-month period. The awards cover a diverse range of categories, reflecting the complexities of the legal and life sciences industries.
About Gowling WLG's Life Sciences
Group
Whether working with biotech startups, research organizations or
large pharmaceutical companies, Gowling WLG's team has the
depth of life sciences experience clients look for, and a strong
track record in the radiopharma industry. By engaging us,
you'll gain access to advice on all relevant legal issues from
professionals who are immersed in your sector and can guide you
through every stage of your products' life cycles, as well as
your company's development. Learn more about Gowling WLG's Life Sciences
Group.